We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Mitsubishi Tanabe Pharma America, Inc. will conduct a study to identify and measure specific biomarkers in people with amyotrophic lateral sclerosis (ALS).....
Ampersand Capital Partners has completed the acquisition of Pacific Biomarkers and merged it with existing portfolio company Neomed-Labs. This merger brings together two bioanalytical